Core Technology

At Sanar Biotech, our protein therapy is designed with a focus on safety, efficacy, and ethical production. Derived from human thrombomodulin and produced using an animal-free system, our technology is developed to meet the highest standards. Below are the key elements driving our innovation.

BB-101

Innovative Recombinant Protein

01

Natural Thrombomodulin Backbone

  • Derived from human thrombomodulin, offering low allergic risk.
  • Stimulates migration in endothelial and epithelial cells, promoting wound healing.
  • Supports angiogenesis, demonstrated through vascular tube formation in the MatriGel Assay.

02

Phase I-II Clinical Trial Safety Confirmation

Our protein has been confirmed safe through Phase II trials for diabetic foot ulcer (DFU) wound healing, demonstrating its potential for therapeutic use.

03

Animal-Free Pichia Expression

Our protein is produced using an animal-free Pichia expression system, ensuring ethical and sustainable manufacturing.

04

PIC/S GMP Manufacturing

All production processes adhere to the highest quality standards under the PIC/S GMP guidelines, ensuring consistency and safety.

SANAR BIOTECH CORP.

© Copyright –SANAR BIOTECH CORP.